Queen Mary Innovation

Menu

News

November 2017

Milestone successfully delivered: 3rd Street Diagnostics and QMUL Licence agreement - Development of a diagnostic test for the early detection of pancreatic cancer
10 November 2017

QMUL Spin-out To Make Novel Light-based Silicon Chips
8 November 2017

QMUL spin out receives investment to develop energy-saving optical communications technology
3 November 2017

October 2017

POST-DOCTORAL INNOVATOR AWARD 2017
25 October 2017

QMUL and Barts Health : Innovation Day and Awards
25 October 2017

QMUL and Barts Health : Innovation Day and Awards
25 October 2017

BioMoti, Pharmidex and Queen Mary University of London secure £662,222 Biomedical Catalyst award
16 October 2017

ANGLE signs option over patent applications  filed on Barts Cancer Institute’s discovery of megakaryocytes’ role in cancer
3 October 2017

June 2017

QMUL Enterprise Investment Fund
15 June 2017

April 2017

QMUL spin-out’s role recognised in award for innovative CCTV solution
24 April 2017

QMUL spin-out’s role recognised in award for innovative CCTV solution
24 April 2017

March 2017

QMI and Barts Health raise funds for the clinical evaluation of the ValGo device to treat SVT
2 March 2017

December 2016

Winners of Barts Health Innovations in Healthcare Awards 2016
21 December 2016

Winners of the Post-doctoral Innovator prizes competition 2016
12 December 2016

October 2016

Research and technology commercialisation open sessions
31 October 2016

Call for post-doctoral scientists with an invention or idea that could lead to a commercial opportunity
18 October 2016

August 2016

BioMoti Ltd and QMUL have signed a Share Purchase Agreement with Physiomics plc
19 August 2016

Dundee Drug Discovery Unit call to fund drug discovery collaborations
17 August 2016

The Dundee Drug Discovery Unit (DDU) calls to fund drug discovery collaborations
17 August 2016

June 2016

Dr Johann Grundlingh presented a lecture on developing the Valsalva Manoeuvre device at Research Matters: Changing lives in East London and beyond
2 June 2016

Queen Mary Innovation Ltd and Barts Health NHS trust to launch crowdfunding platform in September 2016
2 June 2016

February 2016

Regenerate Life Science formed following positive Phase II clinical trial results in Stem Cell Therapy
18 February 2016

October 2015

Affordability of New Drugs and Strategies and Funding of Clinical Trials
28 October 2015

August 2015

QMUL study reveals biomarkers for pancreatic cancer
11 August 2015

December 2014

Queen Mary Spinout Stealthyx Therapeutics Ltd. Secures £2m Series A Funding
16 December 2014
Queen Mary Spinout Stealthyx Therapeutics Ltd. Secures £2m Series A Funding

QMI Company Receives Prestigious Business IT Innovation Award
3 December 2014
Actual Experience, an analytics as a service company spun out of Queen Mary Innovation, has won the 'Business IT Innovation of the Year' award at the recent 2014 UK IT Industry Awards gala.

November 2014

Warblr App can be used for identifying bird song
28 November 2014
Queen Mary Innovation (QMI), has provided the initial funding for a new app called Warblr, which can be used to record bird song using a mobile phone, and then be used to identify the specific bird song.

July 2014

New Game Combines the Fun of Tetris with the Teamwork of Minecraft, and all in an 80s Style
21 July 2014
QApps, Queen Mary University of London's app store, has released Icon Do Better, a new social twist on classic games like Tetris that stack and match falling blocks or icons in a race to keep the screen from overflowing.

June 2014

MRC Technology Sells Its Melanocortin Receptors Programme to Pfizer Inc
18 June 2014
QMI is pleased to announce that its collaborative melanocortin receptors (MCRs) programme with MRCT has been acquired by Pfizer Inc.

QMI Entrepreneur Receives Royal Recognition
18 June 2014
Dr Joushua Reiss, co-founder of QMI portfolio company, MixGenius and QMUL scientist, attended a prestigious reception hosted by Her Majesty the Queen at Buckingham Palace on Monday 9 June to recognise the growing potential of UK tech start-ups.

March 2014

Queen Mary Scientists devise new fibre optic technology
25 March 2014
Researchers at Queen Mary University of London have developed a new method of fabricating a material which has the potential to improve the effectiveness of fibre optic technology and revolutionise the telecommunications industry.

Activiomics Limited, a UK proteomics start-up company is acquired by Retroscreen Virology Group plc (AIM: RVG) in a £4.0m all-share deal.
4 March 2014
Queen Mary Innovation Limited,  Queen Mary University of London’s wholly-owned technology transfer company,acknowledges today’s announcement by Retroscreen Virology Group plc (“Retrosreen”), the viral challenge and “virometrics” specialist, of its acquisition of Activiomics Limited (“Activiomics” or the “Company”) for a total consideration of up to £4.0 million in new ordinary shares of 5 pence each in Retroscreen.  Activiomics is a private UK based proteomics company with a powerful technology for protein identification which will help Retroscreen to mine its biological samples for novel insights into target diseases.

February 2014

QMI celebrates another spin-out success as Actual Experience lists on AIM
13 February 2014
QMI, the technology transfer arm of Queen Mary University of London, is celebrating the listing of another spinout company after Actual Experience (AE) joined the Alternative Investment Market this week, valuing the company at £15.5 milllion.